• Users Online: 194
  • Print this page
  • Email this page

Current Issue

January-March 2020| Vol 3| Issue 1

Letter to the Editor

Cancer immunotherapy for immunocompromised patients: An often ignored, yet vital puzzle

Dear Editor, I have read the recent issue of the Journal of Immunotherapy and Precision Oncology, edited by Dr. Joud Hajjar, with immense enthusiasm. It describes“Cancer immunotherapy in immu...

Review Article

Immune checkpoint blockade in gastrointestinal cancers: The current status and emerging paradigms

Immunotherapy is a rapidly evolving treatment paradigm that holds promise to provide long-lasting survival benefits for patients with cancer. This promise, however, remains unfulfilled for the major...

Review Article

Bromodomain and extra-terminal (BET) domain protein inhibitors for solid tumor cancers

The bromodomain and extraterminal (BET) domain protein family is involved in the process of transcription of genetic information. The BET protein family includes BRD2, BRD3, BRD4, and bromodomain te...

Case Report

Ramucirumab and docetaxel in patients with metastatic urothelial carcinoma harboring fibroblast growth factor receptor alterations: A case series and literature review

Metastatic urothelial carcinoma (mUC) has a poor prognosis with a 5-year survival probability of 4.8%. The mainstay of first-line treatment is platinum-based chemotherapy. Second-line therapy i...

Case Report

Pneumocystis infection in two patients treated with both immune checkpoint inhibitor and corticoids

The introduction of immune checkpoint inhibitor (ICI) targeting cytotoxic T-lymphocyte-associated antigen-4 and programmed cell death receptor 1 has dramatically improved clinical outcome for cancer...

View All Articles in the Current Issue

Journal of Immunotherapy and Precision Oncology, a publication of Global Academy for Health Sciences, is a peer-reviewed print + online Quarterly journal.

Features of Manuscript Management System

  • Online submission
  • Wider visibility through open access
  • Higher impact
  • Prompt review
Special issue 2019

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris Primo Central, Google Scholar, Hinari, Infotrieve, Netherlands ISSN center , ProQuest, TdNet, Wanfang Data